| Completed | A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy Vulvovaginal Atrophy, Menopause, Dyspareunia | Phase 2 | 2016-02-15 |
| Completed | Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hype Benign Prostatic Hyperplasia | Phase 2 | 2013-08-01 |
| Completed | Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women With Dyspare Vulvovaginal Atrophy | Phase 3 | 2013-04-12 |
| Terminated | Efficacy & Safety of Single Dose Alprostadil Cream (2 Concentrations Enhancer) to Vehicle in Men w/Erectile Dy Erectile Dysfunction | Phase 2 | 2013-02-01 |
| Completed | Multicenter Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women Vulvovaginal Atrophy | Phase 3 | 2013-01-31 |
| Completed | Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream) Vulvovaginal Atrophy | Phase 3 | 2011-10-20 |
| Completed | Safety & Efficacy WC3011 (Estradiol Vaginal Cream) in the Treatment of Vulvovaginal Atrophy in Postmenopausal Postmenopausal Vulvovaginal Atrophy | Phase 3 | 2011-06-29 |
| Completed | Effect of Udenafil on Spermatogenesis Spermatogenesis, Erectile Dysfunction | Phase 1 | 2010-09-01 |
| Completed | Treatment of Chlamydia Infection Comparing WC2031 Tablets With Vibramycin Urogential Chlamydia Trachomatis Infection | Phase 3 | 2010-04-01 |
| Completed | Treatment of Erectile Dysfunction - Long Term Safety and Efficacy Erectile Dysfunction | Phase 3 | 2010-01-01 |
| Terminated | Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance Ulcerative Colitis | Phase 3 | 2009-10-01 |
| Completed | Treatment of Erectile Dysfunction II Erectile Dysfunction | Phase 3 | 2009-09-01 |
| Completed | Treatment of Erectile Dysfunction I Erectile Dysfunction | Phase 3 | 2009-09-01 |
| Terminated | Assessing the Safety/Efficacy of Transdermal Testosterone in Female Patients With Symptomatic Heart Failure Heart Failure | Phase 2 | 2009-07-01 |
| Completed | Delayed Release (DR) Risedronate Compared to Immediate Release (IR) in Postmenopausal Women Postmenopausal Osteoporosis | Phase 2 | 2009-05-01 |
| Completed | Study Assessing Dosing Time and Calcium and Vitamin D on the Relative BA of 35 mg DR Risedronate Dosed With Fo Healthy | Phase 1 | 2009-03-01 |
| Completed | A Study to Assess the Bioequivalence of Different Formulations of Risedronate in Healthy Male and Female Subje Osteoporosis | Phase 1 | 2009-01-01 |
| Completed | Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerati Ulcerative Colitis | Phase 3 | 2008-12-01 |
| Terminated | A Two-week Open-label Pharmacodynamic and Pharmacokinetic Study of Multiple Doses of a Darifenacin Liquid Oral Neurogenic Detrusor Overactivity | Phase 2 | 2008-10-07 |
| Completed | Food Effects on the Relative Bioavailability of Different Dosages of Risedronate Postmenopausal, Non-lactating, Surgically Sterile | Phase 1 | 2008-07-01 |
| Terminated | Bone Microarchitecture in Osteopenic Postmenopausal Women Osteoporosis | Phase 4 | 2008-07-01 |
| Completed | Treatment of Acne Vulgaris With Doryx Tablets Compared to Doxycyline Hyclate Acne Vulgaris | Phase 4 | 2008-03-01 |
| Completed | Treatment of Moderate to Severe Facial Acne Vulgaris Acne Vulgaris | Phase 2 | 2008-02-01 |
| Completed | Assess Bioequivalence of One 150 mg Risedronate Tablet Versus Two 75 mg Risedronate Tablets in Healthy Subject Osteoporosis | Phase 1 | 2008-01-01 |
| Completed | Asacol Acute Diverticulitis(DIVA)Study Diverticulitis | Phase 2 | 2007-11-01 |
| Completed | Assess the Influence of a High-fat Meal on the Relative Bioavailability Of Two Formulations of Risedronate Bioavailability | Phase 1 | 2007-11-01 |
| Completed | A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis Postmenopausal Osteoporosis | Phase 3 | 2007-10-01 |
| Completed | Fecal Biomarker Study for Patients With Ulcerative Colitis Ulcerative Colitis | — | 2007-08-01 |
| Completed | A Comparison of Once a Day Dose Compared to 2 Doses/Day Ulcerative Colitis | Phase 3 | 2007-07-01 |
| Completed | Bioequivalence of Testosterone Reduced-size Patch Relative to the Testosterone Reference Patch Healthy | Phase 1 | 2007-07-01 |
| Completed | Study of Safety and Efficacy of an Oral Contraceptive Contraception | Phase 3 | 2007-06-01 |
| Completed | Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women Hypoactive Sexual Desire Disorder | Phase 3 | 2007-04-01 |
| Completed | Pharmacokinetics of Asacol 2.4 g/Day and Lialda 2.4 g/Day in Healthy Volunteers Healthy | Phase 1 | 2007-03-01 |
| Completed | Study of Safety and Efficacy of an Oral Contraceptive Contraception | Phase 3 | 2006-11-01 |
| Completed | Testosterone Therapy in Naturally Menopausal Women With Low Sexual Desire Receiving Transdermal Estrogen Hypoactive Sexual Desire Disorder | Phase 3 | 2006-11-01 |
| Completed | Assess the Safety, Efficacy, and Pharmacokinetics of Immediate and Delayed Release Weekly Risedronate Postmenopausal Women | Phase 2 | 2006-07-01 |
| Completed | A Double Blind Study for the Treatment of Acute Ulcerative Colitis Ulcerative Colitis | Phase 3 | 2006-06-01 |
| Completed | Study of Bleeding With Extended Administration of an Oral Contraceptive Contraception | Phase 2 | 2006-06-01 |
| Completed | Study of the Effect of Once a Week Risedronate on the Microstructure of Tibia and Radius Using a New Scanning Osteopenia | Phase 3 | 2006-04-01 |
| Terminated | A Study of Asacol Absorption, Metabolism and Excretion in Children and Adolescents With Ulcerative Colitis. Ulcerative Colitis | Phase 1 | 2005-10-01 |
| Completed | A Study of Monthly Risedronate for Osteoporosis Postmenopausal Osteoporosis | Phase 3 | 2005-10-01 |
| Completed | Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children Osteogenesis Imperfecta | Phase 3 | 2004-11-01 |
| Completed | Study of Transdermal Testosterone Patches in Menopausal Women With Low Libido Hypoactive Sexual Desire Disorder | Phase 3 | 2004-07-01 |
| Completed | Safety, Pharmacokinetics, and Efficacy of 100, 150, and 200 mg Risedronate Administered to Women With Low BMD Postmenopausal | Phase 2 | 2004-04-01 |
| Completed | Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Alendronate or R Postmenopausal Osteoporosis | — | 2004-01-01 |
| Completed | Study of Safety and Efficacy of an Oral Contraceptive Prevention of Pregnancy | Phase 3 | 2004-01-01 |
| Completed | Study to Assess BMD and Bone Turnover Response to 5 mg Daily Risedronate Treatment in Women With PMO Postmenopausal Osteoporosis | Phase 3 | 2003-06-01 |
| Completed | Analysis of Iliac Crest Biopsies From Patients Receiving Risedronate Osteoporosis | — | 2003-04-01 |
| Completed | Hormone Replacement Therapy for Use in Postmenopausal Women for Relief of Hot Flushes and Urogenital Symptoms. Hormone Replacement Therapy | Phase 3 | 2003-02-01 |
| Completed | Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Osteopenia, Osteoporosis | Phase 1 | 2002-11-01 |
| Completed | Efficacy and Safety of Risedronate Therapy Administered 35 mg Once A Week in Men With Osteoporosis Other Osteoporosis | Phase 3 | 2002-06-01 |
| Completed | Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido Hypoactive Sexual Desire Disorder | Phase 3 | 2002-06-01 |
| Completed | Study to Assess the Efficacy/Safety of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Hypoactive Sexual Desire Disorder (HSDD) | Phase 3 | 2002-06-01 |
| Completed | Study of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido Hypoactive Sexual Desire Disorder | Phase 3 | 2002-06-01 |
| Completed | Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido Hypoactive Sexual Desire Disorder | Phase 3 | 2002-05-01 |
| Completed | Effect of Stopping Risedronate After Long Term Treatment on Bone Turnover Postmenopausal Women With Osteoporosis | Phase 3 | 2001-10-01 |
| Completed | Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I) Ulcerative Colitis | Phase 3 | 2001-02-01 |
| Completed | Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis Ulcerative Colitis | Phase 3 | 2000-09-01 |